Breakthrough in Spinal Cord Injury Treatment: New Study Demonstrates Potential for Regeneration and Functional Recovery

Strategic Insights -

A recent study published in the journal Advanced Science has made a groundbreaking discovery in the treatment of spinal cord injuries. According to the research, a new approach using pharmacological microglial modulation has shown promise in remodelling the scar microenvironment to support reticulospinal circuit reconstruction after spinal cord injury. This innovative treatment has the potential to enable patients with complete spinal cord injuries to regain motor function.

Key Takeaways:

  • The study, led by researchers at Zhejiang University School of Medicine, found that early b2-adrenergic receptor agonist treatment drives microglial transition to a homeostatic phenotype within the post-SCI scar.
  • This intervention reduces inhibitory extracellular matrix deposition and transforms the inhibitory microenvironments into permissive substrates for axonal regrowth.
  • Anatomical analyses reveal regeneration of the reticulospinal tract, which establishes synaptic connectivity with thoracolumbar circuits to mediate motor recovery in a complete SCI.
  • The findings elucidate the therapeutic potential and neural circuit mechanisms underlying pharmacological microglial modulation for SCI repair, establishing a glial-neural circuit reparative paradigm.
  • The study was supported by the National Natural Science Foundation of China and the Natural Science Foundation of Zhejiang Province.
  • The research team, led by Hongyuan Xing, includes Run Li, Yifan Shen, Meng Chen, Bowen Lyu, Xiaofeng Yang, Li Sun, Chao Jiang, Jianyu Lv, Xin Ding, Zhongyang Gao, and Yue Wang.

Statistics:

  • The study published in Advanced Science in 2025.
  • The research team consisted of 12 authors from Zhejiang University School of Medicine and First Affiliated Hospital.
  • The study received funding from two organizations: National Natural Science Foundation of China and the Natural Science Foundation of Zhejiang Province.
  • The researchers found significant reduction in inhibitory extracellular matrix deposition and transformation of inhibitory microenvironments into permissive substrates for axonal regrowth.
  • Regeneration of the reticulospinal tract was observed in a complete SCI model, establishing synaptic connectivity with thoracolumbar circuits to mediate motor recovery.

Sources:

  • NewsRx LLC, "Researchers at Zhejiang University School of Medicine Report New Data on Spinal Cord Injury (Pharmacological Microglial Inhibition Remodels the Scar Microenvironment to Support Reticulospinal Circuit Reconstruction After Spinal Cord Injury)," Health & Medicine Week, October 31, 2025.
  • Hongyuan Xing et al., "Pharmacological Microglial Inhibition Remodels the Scar Microenvironment to Support Reticulospinal Circuit Reconstruction After Spinal Cord Injury," Advanced Science, 2025.
  • Advanced Science, "Pharmacological Microglial Inhibition Remodels the Scar Microenvironment to Support Reticulospinal Circuit Reconstruction After Spinal Cord Injury," vol. 2025, no. 11, pp. 6379, 2025.